KR940703713A - 마이크로캡슐의 제조방법(verfahren zur herstellung von mi-krokapseln) - Google Patents
마이크로캡슐의 제조방법(verfahren zur herstellung von mi-krokapseln)Info
- Publication number
- KR940703713A KR940703713A KR1019940702042A KR19940702042A KR940703713A KR 940703713 A KR940703713 A KR 940703713A KR 1019940702042 A KR1019940702042 A KR 1019940702042A KR 19940702042 A KR19940702042 A KR 19940702042A KR 940703713 A KR940703713 A KR 940703713A
- Authority
- KR
- South Korea
- Prior art keywords
- solvent
- biodegradable
- water
- microcapsules
- dissolved
- Prior art date
Links
- 239000002904 solvent Substances 0.000 claims abstract 12
- 239000003094 microcapsule Substances 0.000 claims abstract 11
- 238000000034 method Methods 0.000 claims abstract 7
- 229920000642 polymer Polymers 0.000 claims abstract 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract 6
- 239000000556 agonist Substances 0.000 claims abstract 5
- 102000004190 Enzymes Human genes 0.000 claims abstract 4
- 108090000790 Enzymes Proteins 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 4
- 229940079593 drug Drugs 0.000 claims abstract 3
- 150000005374 primary esters Chemical class 0.000 claims abstract 3
- 239000000126 substance Substances 0.000 claims abstract 3
- 229920006237 degradable polymer Polymers 0.000 claims abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 2
- 102000004169 proteins and genes Human genes 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract 2
- 239000000725 suspension Substances 0.000 claims abstract 2
- 238000004519 manufacturing process Methods 0.000 claims 5
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 1
- 229920002988 biodegradable polymer Polymers 0.000 claims 1
- 239000004621 biodegradable polymer Substances 0.000 claims 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims 1
- 229940011051 isopropyl acetate Drugs 0.000 claims 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229910052709 silver Inorganic materials 0.000 claims 1
- 239000004332 silver Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000001993 wax Substances 0.000 abstract 2
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
- B01J13/043—Drying and spraying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution
Abstract
생물학적으로 분해 가능한 중합체를 바탕으로 생물학적 분해 가능한 용매를 사용해서 그 이외의 독성 용매 없이도 마이크로캡슐을 생산하는 마이크로캡슘의 제조 과정에 관해 설명하였다. 사용된 용매는 일차 에스테르이고 이 에스테르는 C1-C3-알콜과 C2-C3-모노카르본산과 에스테르의 혼합물로 이루어져 있다. 이러한 용매는 첨가물 C2-C3-알콜을 가지고 있을수 없다. 작용 물질로써 물에 녹거나 녹지 않는 물질이 사용된다. 약제, 펩타이드, 단백질, 효소, 왁찐과 같이 물에 용해되는 작용 물질은 중합체 용액에서 물로된 용액으로써 미세분된다. 마이크로캡슐은 용액의 분무, 현탁액, 작용 물질과 생물학적 분리 가능한 중합체로부터의 W/O-미세분을 통해 얻어진다. 이과정은 약제, 왁찐, 효소 제조에 사용된다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 생물학적으로 분해 가능한 중합체를 가지고 만든 마이크로캡슐의 제조 과정은 생물학적 분해 가능한 중합체가 생물학적으로 분해되는 용매로 용해 되어질 수 있다는 것을 통해(1단계), 작용 물질이 중합체용액으로 감입되어진다는 것을 통해(2단계), 그러면서 작용물질이 생물학적 분해되는 용매 속에서 용해 되어지고(3단계) 그것을 통해 얻은 유기적인 작용 물질 용액과 중합체 용액이 혼합되고(4단계) 또는 중합체 용액속에서 현탁되거나(5단계) 물로된 매개체 속에서 용해 되고(6단계) 그것을 통해 물로된 작용 물질 용액이은 중합체 용액에서 미세하게 미세분되고(7단계) 용액, 현탁액, W/O-미세분 그다음에 분무 건조되어지는(8단계)것을 특징으로하는 마이크로캡슐의 제조방법.
- 제 1 항에 있어서, 생물학적 분해 가능한 용매로 최소한 일차 에스테르가 사용되어 지는 것을 특징으로 한 마이크로캡슐의 제조방법.
- 제 1 항에 있어서, 생물학적 분해 가능한 용매로 최소한 일차 에스테르와 C1-C5알콜이 사용되어 지는것을 특징으로 한 마이크로캡슐의 제조방법.
- 제 1 항 내지 제 3 항에 있어서, C1-C3-알콜과 C1-C3모노카르본산으로 구성되어진 일차 에스테르가 사용되어 지는것을 특징으로 한 마이크로캡슐의 제조방법.
- 제 1 항에 있어서, 생물학적 분해 가능한 용매로 개미산에틸에스테르가 사용되어 지는것을 특징으로 한 마이크로캡슐의 제조방법.
- 제 1 항에 있어서, 생물학적 분해 가능한 용매로 초산에틸에스테르 또는 초산이소프로필에스테르가 사용되어 지는 것을 특징으로 한 마이크로캡슐의 제조방법.
- 제 1 항에 있어서, 생물학적 분해 가능한 용매 속에서 용해되지 않는 작용 물질이 물로된 매개체에서 용해되어지고(6단계) 초음파를 통해 생물학적 분해 가능한 용매 속에서 미세하게 미분화 되는 것을 특징으로 한 마이크로캡슐의 제조방법.
- 제 1 항 내지 제 7 항에 있어서, 작용 물질로서 약제, 펩타이드, 단백질, 효소, 왁찐이 사용되는 것을 특징으로 한 마이크로캡슐의 제조방법.
- 제 1 항 내지 제 8 항에 있어서, 작용 물질이 고체 또는 액체 형태로 사용되는 것을 특징으로 한 마이크로캡슐의 제조방법.
- 약제, 왁찐, 효소를 함유한 마이크로캡슐 제조를 위한 청구범위 제 1 항 내지 제 9 항의 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH331992 | 1992-10-26 | ||
CH3319/92-3 | 1992-10-26 | ||
PCT/CH1993/000246 WO1994009898A1 (de) | 1992-10-26 | 1993-10-18 | Verfahren zur herstellung von mikrokapseln |
Publications (2)
Publication Number | Publication Date |
---|---|
KR940703713A true KR940703713A (ko) | 1994-12-12 |
KR100225983B1 KR100225983B1 (ko) | 1999-10-15 |
Family
ID=4253421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940702042A KR100225983B1 (ko) | 1992-10-26 | 1993-10-18 | 마이크로캡슐의 제조 방법 |
Country Status (14)
Country | Link |
---|---|
US (1) | US5648096A (ko) |
EP (1) | EP0625069B1 (ko) |
JP (1) | JP3523254B2 (ko) |
KR (1) | KR100225983B1 (ko) |
CN (1) | CN1058864C (ko) |
AT (1) | ATE175132T1 (ko) |
CA (1) | CA2126685C (ko) |
DE (1) | DE59309257D1 (ko) |
DK (1) | DK0625069T3 (ko) |
ES (1) | ES2127835T3 (ko) |
FI (1) | FI943067A (ko) |
GR (1) | GR3029504T3 (ko) |
HU (1) | HU221308B1 (ko) |
WO (1) | WO1994009898A1 (ko) |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5693343A (en) | 1984-03-16 | 1997-12-02 | The United States Of America As Represented By The Secretary Of The Army | Microparticle carriers of maximal uptake capacity by both M cells and non-M cells |
US6410056B1 (en) | 1984-03-16 | 2002-06-25 | The United States Of America As Represented By The Secretary Of The Army | Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix |
USRE40786E1 (en) | 1984-03-16 | 2009-06-23 | The United States Of America As Represented By The Secretary Of The Army | Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres |
US20030161889A1 (en) * | 1984-03-16 | 2003-08-28 | Reid Robert H. | Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
US6217911B1 (en) * | 1995-05-22 | 2001-04-17 | The United States Of America As Represented By The Secretary Of The Army | sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres |
US6309669B1 (en) | 1984-03-16 | 2001-10-30 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix |
AU8303691A (en) | 1991-04-24 | 1992-12-21 | United States Of America, As Represented By The Secretary Of The Army, The | Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
JP3583128B2 (ja) * | 1993-01-08 | 2004-10-27 | シーエスエル、リミテッド | ワクチン製剤 |
US6939546B2 (en) | 1993-05-21 | 2005-09-06 | The United States Of America As Represented By The Secretary Of The Army | Model for testing immunogenicity of peptides |
US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
US6855331B2 (en) | 1994-05-16 | 2005-02-15 | The United States Of America As Represented By The Secretary Of The Army | Sustained release hydrophobic bioactive PLGA microspheres |
US6447796B1 (en) | 1994-05-16 | 2002-09-10 | The United States Of America As Represented By The Secretary Of The Army | Sustained release hydrophobic bioactive PLGA microspheres |
GB9420355D0 (en) | 1994-10-10 | 1994-11-23 | Univ Nottingham | Preparation of protein microspheres, films and coatings |
GB9423419D0 (en) * | 1994-11-19 | 1995-01-11 | Andaris Ltd | Preparation of hollow microcapsules |
US6333021B1 (en) * | 1994-11-22 | 2001-12-25 | Bracco Research S.A. | Microcapsules, method of making and their use |
US7033608B1 (en) | 1995-05-22 | 2006-04-25 | The United States Of America As Represented By The Secretary Of The Army | “Burst-free” sustained release poly-(lactide/glycolide) microspheres |
US6902743B1 (en) * | 1995-05-22 | 2005-06-07 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix |
WO1997013503A1 (en) * | 1995-10-13 | 1997-04-17 | The Penn State Research Foundation | Synthesis of drug nanoparticles by spray drying |
JP2000500744A (ja) | 1995-11-09 | 2000-01-25 | マイクロバイオロジカル リサーチ オーソリティー | ワクチン接種および遺伝子治療のためのマイクロカプセル化dna |
US6270795B1 (en) | 1995-11-09 | 2001-08-07 | Microbiological Research Authority | Method of making microencapsulated DNA for vaccination and gene therapy |
DE19545257A1 (de) | 1995-11-24 | 1997-06-19 | Schering Ag | Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln |
US5980945A (en) * | 1996-01-16 | 1999-11-09 | Societe De Conseils De Recherches Et D'applications Scientifique S.A. | Sustained release drug formulations |
FR2757510B1 (fr) * | 1996-12-23 | 2000-01-07 | Sanofi Sa | Forme microparticulaire d'un derive de tetrahydropyridine |
JP2001507702A (ja) | 1996-12-31 | 2001-06-12 | インヘイル・セラピューティックス・システムズ・インコーポレテッド | 親水性賦形剤を有する疎水性薬剤の水性懸濁液を噴霧乾燥させる方法およびその方法によって作製された組成物 |
US20030203036A1 (en) | 2000-03-17 | 2003-10-30 | Gordon Marc S. | Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients |
US20020182258A1 (en) * | 1997-01-22 | 2002-12-05 | Zycos Inc., A Delaware Corporation | Microparticles for delivery of nucleic acid |
US5783567A (en) * | 1997-01-22 | 1998-07-21 | Pangaea Pharmaceuticals, Inc. | Microparticles for delivery of nucleic acid |
US6126919A (en) * | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
US20050171408A1 (en) * | 1997-07-02 | 2005-08-04 | Parker Jeffery R. | Light delivery systems and applications thereof |
ATE241980T1 (de) * | 1997-08-08 | 2003-06-15 | Rotta Research Lab | Neue inhalationspräparate enthaltend cr 2039 (andolast) |
US6716823B1 (en) | 1997-08-13 | 2004-04-06 | The Uab Research Foundation | Noninvasive genetic immunization, expression products therefrom, and uses thereof |
US20030045492A1 (en) * | 1997-08-13 | 2003-03-06 | Tang De-Chu C. | Vaccination by topical application of recombinant vectors |
US20030125278A1 (en) * | 1997-08-13 | 2003-07-03 | Tang De-Chu C. | Immunization of animals by topical applications of a salmonella-based vector |
US6348450B1 (en) | 1997-08-13 | 2002-02-19 | The Uab Research Foundation | Noninvasive genetic immunization, expression products therefrom and uses thereof |
UA65607C2 (uk) | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
DK1061948T3 (da) | 1998-03-20 | 2003-03-31 | Takeda Chemical Industries Ltd | Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf |
GB9810236D0 (en) | 1998-05-13 | 1998-07-08 | Microbiological Res Authority | Improvements relating to encapsulation of bioactive agents |
US6406719B1 (en) | 1998-05-13 | 2002-06-18 | Microbiological Research Authority | Encapsulation of bioactive agents |
CA2335460A1 (en) | 1998-06-18 | 1999-12-23 | Johns Hopkins University School Of Medicine | Polymers for delivery of nucleic acids |
US7087236B1 (en) | 1998-09-01 | 2006-08-08 | Merrion Research I Limited | Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof |
US20040009936A1 (en) * | 1999-05-03 | 2004-01-15 | Tang De-Chu C. | Vaccine and drug delivery by topical application of vectors and vector extracts |
US20050037086A1 (en) * | 1999-11-19 | 2005-02-17 | Zycos Inc., A Delaware Corporation | Continuous-flow method for preparing microparticles |
US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
EP1292285A4 (en) * | 2000-06-02 | 2009-07-22 | Eisai Corp North America | SYSTEMS FOR DISPENSING BIOACTIVE AGENTS |
US7575761B2 (en) * | 2000-06-30 | 2009-08-18 | Novartis Pharma Ag | Spray drying process control of drying kinetics |
AU2001277230A1 (en) * | 2000-08-01 | 2002-02-13 | Inhale Therapeutic Systems, Inc. | Apparatus and process to produce particles having a narrow size distribution andparticles made thereby |
US7666445B2 (en) * | 2000-10-20 | 2010-02-23 | The Trustees Of The University Of Pennsylvania | Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use |
DE10055857A1 (de) * | 2000-11-10 | 2002-08-22 | Creative Peptides Sweden Ab Dj | Neue pharmazeutische Depotformulierung |
US7749539B2 (en) * | 2000-11-30 | 2010-07-06 | Efrat Biopolymers Ltd. | Polymeric formulations for drug delivery |
EP1343480B2 (en) | 2000-12-21 | 2016-02-17 | Alrise Biosystems GmbH | Induced phase transition method for the production of microparticles containing hydrophobic active agents |
US20030224047A1 (en) * | 2001-02-15 | 2003-12-04 | Franz G. Andrew | Levothyroxine compositions and methods |
US20030032675A1 (en) * | 2001-02-15 | 2003-02-13 | Franz G. Andrew | Manufacture of thyroid hormone tablets having consistent active moiety amounts |
US7067148B2 (en) * | 2001-02-15 | 2006-06-27 | King Pharmaceutical Research & Development, Inc. | Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
US20030190349A1 (en) * | 2001-08-10 | 2003-10-09 | Franz G. Andrew | Methods of stabilizing pharmaceutical compositions |
US20030198667A1 (en) * | 2001-08-10 | 2003-10-23 | Franz Andrew G. | Methods of producing dispersible pharmaceutical compositions |
US20030180353A1 (en) * | 2001-08-10 | 2003-09-25 | Franz G. Andrew | Stabilized pharmaceutical compositions |
US20030198671A1 (en) * | 2001-08-10 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique plasma AUC properties |
US20030198672A1 (en) * | 2001-08-14 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique triidothyronine plasma AUC properties |
US20030199587A1 (en) * | 2001-08-14 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique Cmax properties |
US20030203967A1 (en) * | 2001-08-14 | 2003-10-30 | Franz G. Andrew | Levothyroxine compositions having unique Tmax properties |
US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
US20030199586A1 (en) * | 2001-08-14 | 2003-10-23 | Franz G. Andrew | Unique levothyroxine aqueous materials |
US20030195253A1 (en) * | 2001-08-14 | 2003-10-16 | Franz G. Andrew | Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration |
US7098305B2 (en) * | 2001-09-06 | 2006-08-29 | Ardana Bioscience Limited | Sustained release of microcrystalline peptide suspensions |
US20040043066A1 (en) * | 2001-10-29 | 2004-03-04 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Tmax properties |
EP1446104B2 (en) * | 2001-11-01 | 2011-08-03 | Novartis AG | Spray drying methods |
US20040142902A1 (en) * | 2001-11-08 | 2004-07-22 | Struijker- Boudier Harry A.J. | Implant dosage form and use thereof for the delivery of a cholosterol lowering agent |
US20050182056A9 (en) * | 2002-02-21 | 2005-08-18 | Seth Pawan | Modified release formulations of at least one form of tramadol |
US8128957B1 (en) * | 2002-02-21 | 2012-03-06 | Valeant International (Barbados) Srl | Modified release compositions of at least one form of tramadol |
GB0216562D0 (en) | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
WO2004035028A1 (fr) * | 2002-10-17 | 2004-04-29 | Gosudarstvenny Nauchny Tsentr Virusologii I Biotekhnologii 'vektor' | Procede de production d'une forme microencapsulee d'un vaccin viral vivant |
MXPA05007154A (es) | 2002-12-30 | 2005-09-21 | Nektar Therapeutics | Atomizador prepeliculizacion. |
US7862834B2 (en) * | 2003-05-28 | 2011-01-04 | Novartis Pharma Ag | Pharmaceutical formulation comprising a water-insoluble active agent |
MEP3608A (en) * | 2003-08-08 | 2011-05-10 | Biovail Lab Int Srl | Modified-release tablet of bupropion hydrochloride |
US20050037047A1 (en) * | 2003-08-11 | 2005-02-17 | Young-Ho Song | Medical devices comprising spray dried microparticles |
JP5306599B2 (ja) * | 2004-01-12 | 2013-10-02 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 長期間送達製剤 |
US8221778B2 (en) | 2005-01-12 | 2012-07-17 | The Trustees Of The University Of Pennsylvania | Drug-containing implants and methods of use thereof |
NZ551990A (en) * | 2004-06-04 | 2011-01-28 | Camurus Ab | Liquid depot formulations |
AU2006216671A1 (en) * | 2005-02-23 | 2006-08-31 | The Uab Research Foundation | Alkyl-glycoside enhanced vaccination |
JP5095615B2 (ja) * | 2005-06-27 | 2012-12-12 | バリアント・インターナショナル・(バルバドス)・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ | ブプロピオン塩の放出調整製剤 |
WO2007014445A1 (en) * | 2005-08-02 | 2007-02-08 | Miv Therapeutics Inc. | Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same |
US20070286814A1 (en) * | 2006-06-12 | 2007-12-13 | Medispray Laboratories Pvt. Ltd. | Stable aerosol pharmaceutical formulations |
CN101239296B (zh) * | 2008-03-07 | 2010-04-21 | 清华大学 | 一种制备溶剂微胶囊的方法 |
CN101543757B (zh) * | 2009-04-30 | 2011-05-04 | 上海交通大学 | 利用声表面波雾化器实现芯材微胶囊化的制备方法 |
WO2012009973A1 (zh) * | 2010-07-20 | 2012-01-26 | 上海交通大学医学院附属新华医院 | 一种含有抗帕金森病药物的微球组合药物及其应用 |
US10087401B2 (en) | 2012-03-16 | 2018-10-02 | Monosol, Llc | Water soluble compositions incorporating enzymes, and method of making same |
US9394092B2 (en) | 2012-04-16 | 2016-07-19 | Monosol, Llc | Powdered pouch and method of making same |
CN102698664B (zh) * | 2012-05-26 | 2014-03-12 | 云南恩典科技产业发展有限公司 | 一种包水微胶囊的制备方法 |
CA2879942C (en) | 2012-07-26 | 2020-06-02 | Camurus Ab | Opioid formulations |
CN103506058B (zh) * | 2013-10-09 | 2015-05-13 | 上海理工大学 | 微胶囊喷雾干燥装置 |
CN107108919A (zh) | 2014-10-03 | 2017-08-29 | 蒙诺苏尔有限公司 | 可降解材料和由可降解材料制造的包装 |
EP3233964B1 (en) | 2014-12-18 | 2020-06-17 | Dexcel Pharma Technologies Ltd. | Alternating and semi-alternating poly(ester-anhydride) copolymers |
WO2018178963A1 (en) | 2017-03-29 | 2018-10-04 | Dexcel Pharma Technologies Ltd. | Compositions comprising biodegradable copolymers |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4637905A (en) * | 1982-03-04 | 1987-01-20 | Batelle Development Corporation | Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or ε-caprolactones |
US4530840A (en) * | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
JPS6067417A (ja) * | 1983-09-24 | 1985-04-17 | Tetsuo Kato | 生体内代謝性マイクロカプセルの製法 |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
DE3738228A1 (de) * | 1987-11-11 | 1989-05-24 | Hoechst Ag | Verfahren zur herstellung von bioabbaubaren mikrokapseln wasserloeslicher peptide und proteine sowie nach diesem verfahren erhaltene mikrokapseln |
JP2670680B2 (ja) * | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
ES2051968T3 (es) * | 1988-12-22 | 1994-07-01 | American Cyanamid Co | Metodo para el tratamiento de enfermedad periodontal mediante la liberacion continua de un agente terapeutico a la bolsa periodontal; composicion de materia del mismo y aparato para su administracion. |
IL92344A0 (en) * | 1989-01-04 | 1990-07-26 | Gist Brocades Nv | Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules |
JPH04247987A (ja) * | 1991-01-18 | 1992-09-03 | Fuji Photo Film Co Ltd | 感熱記録材料 |
YU48420B (sh) * | 1991-03-25 | 1998-07-10 | Hoechst Aktiengesellschaft | Postupak za dobijanje biološki razgradljivih mikročestica sa dugotrajnim delovanjem |
-
1993
- 1993-10-18 HU HU9401329A patent/HU221308B1/hu not_active IP Right Cessation
- 1993-10-18 CA CA002126685A patent/CA2126685C/en not_active Expired - Fee Related
- 1993-10-18 KR KR1019940702042A patent/KR100225983B1/ko not_active IP Right Cessation
- 1993-10-18 JP JP51051894A patent/JP3523254B2/ja not_active Expired - Fee Related
- 1993-10-18 DE DE59309257T patent/DE59309257D1/de not_active Expired - Fee Related
- 1993-10-18 EP EP93922486A patent/EP0625069B1/de not_active Expired - Lifetime
- 1993-10-18 DK DK93922486T patent/DK0625069T3/da active
- 1993-10-18 AT AT93922486T patent/ATE175132T1/de not_active IP Right Cessation
- 1993-10-18 WO PCT/CH1993/000246 patent/WO1994009898A1/de active IP Right Grant
- 1993-10-18 ES ES93922486T patent/ES2127835T3/es not_active Expired - Lifetime
- 1993-10-26 CN CN93119645A patent/CN1058864C/zh not_active Expired - Fee Related
-
1994
- 1994-06-22 US US08/264,007 patent/US5648096A/en not_active Expired - Fee Related
- 1994-06-23 FI FI943067A patent/FI943067A/fi not_active IP Right Cessation
-
1999
- 1999-02-26 GR GR990400601T patent/GR3029504T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HU221308B1 (en) | 2002-09-28 |
GR3029504T3 (en) | 1999-05-28 |
US5648096A (en) | 1997-07-15 |
FI943067A0 (fi) | 1994-06-23 |
DK0625069T3 (da) | 1999-08-30 |
CN1090172A (zh) | 1994-08-03 |
FI943067A (fi) | 1994-06-23 |
CA2126685A1 (en) | 1994-05-11 |
KR100225983B1 (ko) | 1999-10-15 |
WO1994009898A1 (de) | 1994-05-11 |
DE59309257D1 (de) | 1999-02-11 |
HU9401329D0 (en) | 1994-08-29 |
EP0625069B1 (de) | 1998-12-30 |
HUT70418A (en) | 1995-10-30 |
EP0625069A1 (de) | 1994-11-23 |
CN1058864C (zh) | 2000-11-29 |
ES2127835T3 (es) | 1999-05-01 |
JP3523254B2 (ja) | 2004-04-26 |
CA2126685C (en) | 2002-07-23 |
ATE175132T1 (de) | 1999-01-15 |
JPH07502686A (ja) | 1995-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR940703713A (ko) | 마이크로캡슐의 제조방법(verfahren zur herstellung von mi-krokapseln) | |
US4532123A (en) | Dual Microcapsules and process for their preparation | |
US4353888A (en) | Encapsulation of live animal cells | |
KR950702868A (ko) | 미세 입자 제조를 위한 에스테르화 다당류와 폴리아민에이트화 또는 폴리히드록실레이트화 물질 사이의 아실 교환 반응의 이용, 이를 통해 수득된 미세 입자, 이의 제조방법 및 이를 함유하는 조성물(utilization of a transacylation reaction between an esterified polysaccharide and a polyaminated or polyhydroxylated substance for fabricating microparticles, microparticles thus obtained, methods and compositions containing them) | |
ATE204469T1 (de) | Verfahren zur herstellung von morphologisch einheitlichen mikrokapseln sowie nach diesem verfahren hergestellte mikrokapseln | |
CA1204058A (en) | Dual microcapsules | |
JPH0411254B2 (ko) | ||
CN1232411A (zh) | 用超临界流体进行微囊包封的方法 | |
US4888420A (en) | Water soluble cellulose acetate microspheres | |
JPH04506931A (ja) | タンパク質マイクロスフェアを生産する方法 | |
US4780321A (en) | Microcapsules having mixed walls formed of reticulated polyholosides and proteins and process for preparation thereof | |
ATE127686T1 (de) | Herstellungsverfahren von mikrokugeln. | |
KR890007789A (ko) | 수용성 펩타이드 및 단백질의 생체분해 가능한 마이크로캡슐의 제조방법 및 이 방법에 의해 수득되는 마이크로캡슐 | |
Lu et al. | Cell encapsulation with alginate and α‐phenoxycinnamylidene‐acetylated poly (allylamine) | |
DE60030999D1 (de) | Verfahren zur herstellung von teilchen | |
US4673595A (en) | Microencapsulation by phase separation of water-soluble medicaments | |
IL156720A (en) | Process for making material particles | |
US4997599A (en) | Preparation of water soluble cellulose acetate microspheres | |
EP0085079B1 (en) | Microencapsulation process | |
US3538216A (en) | Injectable compositions of a drug suspended in an emulsion | |
DE69609738T2 (de) | Verfahren zur Herstellung von Xanthangummi, löslich in einer Salzlösung | |
US5424084A (en) | Process for preparing collagen beads | |
US4195097A (en) | Method for preparing enzymaytic composition for acceleration of ageing of meat products | |
JPH0764723B2 (ja) | 腸溶性製剤の製造法 | |
JPS58111686A (ja) | 安定な酵素含有製剤の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20050711 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |